# Open-Trial of EPI-743 for Adults With Tourette Syndrome

> **NCT01719523** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 10 (actual)

## Conditions studied

- Tourette Syndrome

## Interventions

- **DRUG:** EPI-743

## Key facts

- **NCT ID:** NCT01719523
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2014-03-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01719523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01719523, "Open-Trial of EPI-743 for Adults With Tourette Syndrome". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01719523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
